{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Topical Therapy for Vulvodynia: A Review of the Literature
Activity Steps
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Description
NOTE: Individual subscribers will be required to submit payment before viewing. Users accessing via an institutional subscription can proceed without payment.Learning Objectives
After completing this continuing education activity you will be able to:
- Summarize the diagnosis of vulvodynia based on the multisocietal consensus definition.
- Differentiate among the benefits, limitations, and adverse effects of different topical therapies for vulvodynia.
- Outline the integration of topical therapy into a multimodal treatment regimen for vulvodynia.
Learning Outcomes
Seventy-five percent of participants will demonstrate knowledge of current evidence regarding topical therapies for vulvodynia by achieving a minimum score of 70% on the outcomes-based posttest.Disclosures
Dr. Sobel has disclosed that he serves on the advisory board and as a consultant for SCYNEXIS Inc and Mycovia Pharmaceuticals Inc.
Lippincott CME Institute has identified and mitigated all relevant financial relationships regarding this educational activity. Dr. Demarest, faculty, and staff have no relevant financial relationships with any ineligible organizations regarding this educational activity
Price:
$49.00
Credits:
- ANCC 3.0 CH / 3.0 APH
- DC - BON 3.0 CH
- FL - BON 3.0 CH
- GA - BON 3.0 CH
- NM - BON 3.0 CH
- SC - BON 3.0 CH
- WV - BOERN 3.0 CH
Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.
Awarded Advanced Pharmacology Hours
Awarded Advanced Pharmacology Hours
{{ evaluation.question.text }}
{{choice.text}}
{{evaluation.answerSet[0].text}}
Test Code: PGO0123A
Published: Jan 2023
Expires: 12/5/2025
Required Passing Score: 8/10 (80%)
Categories:
Advanced Pharmacology Hours
,
Advanced Practice Nursing
,
Drug Therapy
,
Genitourinary
,
Gynecological
,
Pain Management
,
Pharmacology
,
Women's Health
Topics:
Vulvodynia